TD Asset Management
XENT

TD Asset Management’s Intersect ENT, Inc XENT Stock Holding History

TD Asset Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,400
Closed -$222K – 1417
2020
Q2 		$222K Hold
16,400
– – ﹤0.01% 1285
2020
Q1 		$194K Buy
+16,400
New +$364K ﹤0.01% 1319

Other funds holding XENT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

TD Asset Management's XENT Position: Q3 2020 in Review

TD Asset Management sold out of Intersect ENT, Inc (XENT) in Q3 2020, closing a stake of 16,400 shares — an estimated $222K sold.

TD Asset Management first reported a position in XENT in Q1 2020 and held it in 2 quarters. The position peaked at $222K in Q2 2020. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2020.

  • TD Asset Management reported no remaining Intersect ENT, Inc position as of Q3 2020 after selling out during the quarter.
  • TD Asset Management sold 16,400 Intersect ENT, Inc shares in Q3 2020, an estimated $222K.
  • TD Asset Management first reported a position in Intersect ENT, Inc in Q1 2020 and held it in 2 quarters.
  • TD Asset Management's Intersect ENT, Inc position peaked at $222K in Q2 2020.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2020.

Based on TD Asset Management's 13F filing for Q3 2020, filed 10 Nov 2020.